Updates in Heart Failure 2023
Chairs: Gianluigi Savarese, Frieder Braunschweig
Organized by: Karolinska University Hospital
In collaboration with Translational Medical Academy Foundation (TMA)
December 11th-12th 2023
DECEMBER 11th 2023 (DAY 1)
12.00-13.00
Lunch
12.00-13.00
- 13.00-13.05 | Greetings and introduction to the congress
Savarese G (SE), Braunschweig F (SE)
Session 1: Updates from the Heart Failure Association of the European Society of Cardiology
Chairpersons: Savarese G (SE), Rosano G (UK), Ponikowski P (PL)
13.20-14.35
- 13.20-13.35 | Updates in European Guidelines on Heart failure: what changes and why?
Metra M (IT) - 13.35-13.50 | Patient profiling in HFpEF: a roadmap to the treatment of patients with HFpEF
Anker S (DE) - 13.50-14.05 | Latest HFA/ESC scientific statements
Chioncel O (RO) - 14.05-14.35 | Round Table: Ask the experts
All
14.35-14-50
Coffee Break
Session 2: Latest updates on SGLT2i – multidisciplinary perspectives
Chairpersons: Braunschweig F (SE), Solomon S (US), Lainscak M (SLO)
14.50-16.20
- 14.50-15.00 | New data on empagliflozin in HF
Anker S (DE) - 15.00-15.10 | New data on dapagliflozin in HF
McMurray J (UK) - 15.10-15.20 | SGLT2i in kidney disease
Lambers Heerspink H (NL) - 15.20-15.30 | SGLT2i in type 2 diabetes
Cosentino F (SE) - 15.30-15.40 | What about the mechanisms?
Ferrannini E (IT) - 15.40-15.50 – What to consider when starting a SGLT2i in a patient with cardiometabolic disease
Rosano G (UK) - 15.50-16.20 | Round Table: Ask the experts
All
16.20-16.35
Coffee Break
Session 3: Iron deficiency in HF: summing up the current evidence
Chairpersons: Maurizio Volterrani (IT), Butler J (US), Ponikowski P (PL)
16.35-17.40
- 16.35-16.45 | Why to screen HF patients for iron deficiency? Epidemiology and Pathophysiology
Von Haehling (DE)
- 16.45-16.55 | Latest data on ferric carboxymaltose
Ponikowki (PL)
- 16.55-17.05 | Latest data on ferric derisomaltose
Cleland J (UK)
- 17.05-17.35 | Round Table: Ask the experts
All
- 17.35-17.55 | Keynote lecture: State-of-the-art on GLP1-Ra in heart failure
Petrie M (UK)
- 17.55-18.00 | Closure of the day
Savarese G (SE), Braunschweig F (SE)
December 12th 2023 (day 2)
DECEMBER 12th 2023 (DAY 2)
- 08.25-08.30 | Welcome and introduction
Savarese G (SE), Braunschweig F (SE)
Session 4: The evolving evidence on potassium binders
08.30-09.30
Chairpersons: Lund LH (SE), Ponikowki (PL)
- 08.30-08.40 | Why do we need potassium binders?
Savarese G (SE) - 08.40-08.50 | Latest data on patiromer
Butler J (US) - 08.50-09:00 | Latest data on SZC
Rosano G - 09.00-09.30 | Round Table: Ask the experts
All
Session 5: Beyond the 4 pillars of pharmacological treatment in HFrEF
09.30-10.40
Chairpersons: Metra M (IT), Swedberg K (SE)
- 09.30-09.40 | Ivabradine
Rosano G (UK) - 09.40-09.50 | Vericiguat
Lund LH (SE) - 09.50-10.00 | Omecamtiv mecarbil
Solomon S (US) - 10.00-10.10 | What is coming next?
Filippatos G (GR) - 10.10-10.40 | Round Table: Ask the experts
All
10.40-10.55
Coffee Break
Session 6: Implementation of GDMT: where do we stand?
10.55-11.55
Chairpersons: Volterrani M (IT), Bayes-Genis A (ES), Cannata A (UK)
- 10.55-11.05 | Status of GDMT implementation worldwide
Savarese G (SE) - 11.05-11.15 | Strategies to implement use of GDMT in HF
Bozkurt B (US) - 11.15-11.25 | Take home messages from the STRONG-HF trial
Chioncel O (RO) - 11.25-11.55 | Round Table: Ask the experts
All
11.55-12.55
Lunch
Session 7: The complicated relationship between ischemic heart disease and heart failure
12.55-14.05
Chairpersons: Lund LH (SE), Lindmark K (SE)
- 12.55-13.05 | The PARADISE-MI trial
Solomon S (US) - 13.05-13.15 | The DAPA-MI
James S (SE) - 13.15-13.25 | The EMPACT-MI
Butler J (US) - 13.25-13.35 | The REVIVED
Petrie M (UK) - 13.35-14.05 | Round Table: Ask the experts
All
Session 8: Heart Failure Devices
14.05-14.55
Chairpersons: Cleland J (UK), Linde C (SE)
- 14.05-14.15 | Primary prophylactic ICD in HF: current debates
Braunschweig F (SE) - 14.15-14.25 | Resynchronization by CRT or conduction system pacing
Burri H (CH) - 14.25-14.35 | MONITOR HF
Brugts J (NL) - 14.35-14.55 | Round Table: Still room for devices on top of pharmacological therapies?
All
14.55-15.10
Coffee Break
Session 9: Treating mitral and tricuspid regurgitation in HF
15.10-16.00
Chairpersons: Savarese G (SE), Braunschweig F (SE)
- 15.10-15.20 | The importance to treat MR and TR in heart failure
Butler J (US) - 15.20-15.35 | Treating MR in the context of HF effectively
Adamo M (IT) - 15.35-15.50 | Treating TR today and tomorrow
Lurz P (DE) - 15.50-16.00 | Round Table: Ask the experts
All
Session 10: The best of HF publications in 2023
16.00-16.40
Chairpersons: Savarese G (SE), Bayes-Genis A (ES)
- 16.00-16.10 | European Journal of Heart Failure
Metra M (IT) - 16.10-16.20 | JACC HF
Bozkurt B (US) - 16.20-16.30 | ESC HF
Bäck M (SE) - 16.30-16.40 | Key learnings and conclusion
Savarese G (SE, Braunschweig F (SE)